Venlafaxine Hydrochloride
Product Images NDC 50090-5731

5 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-5731). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (Lbl500905731)

Label Image (Lbl500905731)
Venlafaxine hydrochloride 75 mg extended-release capsules packaging label from A-S Medication Solutions. The label includes dosage strength, storage instructions to keep between 46 to 77 degrees Fahrenheit, and quantity of 30 capsules. It also notes the NDC 50090-5731 and product number 6226-0.*
FDA Label Image

Fig-1 (Venlafaxine Fig 1)

Fig-1 (Venlafaxine Fig 1)
A pharmacokinetic fold change graph for venlafaxine hydrochloride showing the impact of various interacting drugs on venlafaxine and its metabolite ODV. The y-axis lists interacting drugs and analytes (venlafaxine and ODV), and the x-axis shows changes relative to a reference value with 90% confidence intervals. Recommendations on dosage adjustments or caution for each interacting drug are noted.*
FDA Label Image

Fig-2 (Venlafaxine Fig 2)

Fig-2 (Venlafaxine Fig 2)
A pharmacokinetic (PK) fold change chart showing interactions of venlafaxine hydrochloride with various drugs. It compares Cmax and AUC changes relative to reference values for ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium, including 90% confidence intervals. Recommendations on coadministration or dose adjustments are noted for each interacting drug.*
FDA Label Image

Fig-3 (Venlafaxine Fig 3)

Fig-3 (Venlafaxine Fig 3)
A chart presenting pharmacokinetic changes (Cmax and AUC) of venlafaxine and its metabolite ODV across various special populations, including hepatic and renal impairments, CYP2D6 polymorphism, age, and gender. It shows fold change relative to reference values with recommendations for dose adjustments based on the observed changes.*
FDA Label Image

Str (Venlafaxine Str)

Str (Venlafaxine Str)
Chemical structure of venlafaxine hydrochloride, showing its molecular arrangement including a methoxyphenyl group, cyclohexanol ring, and the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.